Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Table 1
Baseline clinical characteristics between patients with CIN and those without CIN.
Variables
CIN(n=29)
Non-CIN(n=211)
P value
Male,n (%)
18 (62.1)
161 (76.3)
0.099
Age (years)
71.07±13.77
63.06±12.7
0.002
Smoking,n (%)
14 (48.3)
118 (55.9)
0.438
Hypertention,n (%)
24 (82.8)
126 (59.7)
0.016
Diabetes mellitus,n (%)
13 (44.8)
50 (23.7)
0.015
Systolic BP (mm Hg)
127.21±22.72
128.39±22.02
0.585
Diastolic BP (mm Hg)
74.59±13.2
76.65±14.3
0.519
Heart rate (t/min)
82.59±15.99
80.33±17.4
0.486
LV (cm)
5.04±0.49
4.83±0.6
0.029
LVEF (%)
0.47±0.12
0.53±0.11
0.02
Contrast dose (mL)
109.66±23.22
105.17±15.72
0.152
Hydration,n (%)
16 (55.2)
52 (24.6)
0.001
Number of diseased vessels, n
3.1±1.59
2.78±1.26
0.336
Medication,n (%)
Aspirin
27 (93.1)
203 (96.2)
0.433
Ticagrelor
29 (1)
210 (99.5)
0.71
-Blocker
24 (82.8)
175 (82.9)
0.981
ACEI/ARB
11 (37.9)
134 (63.5)
0.008
CCB
4 (13.8)
16(7.6)
0.257
Statin
28 (96.6)
203 (96.2)
0.927
Diuretics
16 (55.2)
65 (30.8)
0.009
Hospitalization (days)
13.62±9.04
10.02±10.17
0.009
Hospitalization costs (RMB)
65245.52±30207.06
59278.88±45699.02
0.127
Data were presented as means ± standard deviation or number(%). BP, blood pressure; LV, left ventricular; LVEF, left ventricular ejection fraction; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker.
